Management options expand in both inpatient and outpatient settings
Novel regimen may help overcome the shortcomings of traditional chemotherapy in geriatric population
Follow-up study confirms safety and tolerability of new treatment protocol
Experts highlight the newest, most compelling hematology abstracts
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Treatment may be a lifesaving option for patients with relapsed or refractory disease
Study suggests new approach is safer than standard treatment and may help prevent graft-versus-host disease
Study suggests re-examining eligibility criteria for randomized controlled trials of hematologic malignancies.
Takeaways from Cleveland Clinic’s hematology/medical oncology experts
Molecular data enhance traditional scoring systems
Research improving myelodysplastic syndromes treatment